Recruiting Obesity Studies in Seattle
Tirzepatide in PWS, HO and GNSO
This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults wi...
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Hypothalamic obesity (HO) refers to the substantial weight gain that often complicates hypothalamic brain tumors. Children with this treatment-recalcitrant form of obesity have excess rates of metabol...
About Obesity Clinical Trials in Seattle
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 60 participants. Research is being sponsored by Grace Kim, Seattle Children's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Seattle — FAQ
Are there obesity clinical trials in Seattle?
Yes, there are 2 obesity clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seattle?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.
Are clinical trials in Seattle free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov